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Abstract.  Lymphocyte attachment to high endothelial 
venules within lymph nodes is mediated by the periph- 
eral lymph node homing receptor (pnHR), originally 
defined on mouse lymphocytes by the MEL-14 mAb. 
The pnHR is a calcium-dependent lectin-like receptor, 
a member of the LEC-CAM family of adhesion proteins. 
Here, using a  soluble recombinant form of the homing 
receptor,  we have identified an endothelial ligand for 
the pnHR as an ,x,50-kD sulfated, fucosylated, and sialy- 
lated glycoprotein, which we designate Sgp  5° (sulfated 
glycoprotein of 50 kD).  Recombinant receptor binding 
to this lymph node-specific glycoprotein requires cal- 
cium and is inhibitable by specific carbohydrates and 
by MEL-14 mAb.  Sialylation of the component is re- 
quired for binding.  Additionally, the glycoprotein is 
precipitated by MECA-79, an adhesion-blocking mAb 
reactive with lymph node HEV. A  related glycoprotein 
of ~,,90 kD (designated as Sgp  9°) is also identified. 
T 
HE trafficking of lymphocytes from the blood into sec- 
ondary lymphoid organs,  such as lymph nodes (LN)  I 
and gut-associated Peyer's patches (PP), is initiated by 
an adhesive interaction with the specialized endothelial  cells 
of high endothelial  venules (HEV) (Berg et al., 1989; Duij- 
vestijn and Hamann,  1989; Woodruff et al.,  1987; Yednock 
and Rosen, 1989; Stoolman, 1989). Considerable evidence 
indicates  that  the  lymphoid  organ-selective  migration  or 
"homing" of lymphocytes is dictated in large part by organ- 
specific binding  of lymphocytes to HEV (Butcher,  1986). 
Operationally,  the lymphocyte-associated molecules under- 
lying the organ-selective  interaction  with HEV are termed 
"homing receptors" while the cognate endothelial  molecules 
are known as "HEV ligands" (GaUatin et al.,  1986; Rosen, 
1989). These endothelial ligands are postulated to be distinc- 
tive for the different lymphoid organs  and as such are pro- 
posed to be responsible for regulating the lymphocyte popu- 
lations  that  enter each class of lymphoid organ  (Butcher, 
1990). Strong support for organ-specific  HEV determinants 
has come with the discovery of the mouse "vascular addres- 
sin" antigens, defined by the panel of MECA mAbs (Streeter 
et al.,  1988a,  b). MECA-79 differentially  stains and selec- 
tively blocks the adhesive function  of HEV in peripheral 
lymph nodes (PN) while MECA-367 shows the converse pat- 
tern of reactivity with HEV of Peyer's patches  (PP). 
Of the homing  receptors, the most thoroughly studied is 
the peripheral  lymph node homing  receptor (pnHR),  ini- 
1. Abbreviations used in thispaper: C-type, calcium type; HEV, high endo- 
thelial  venule;  LN,  lymph  nodes;  M6P, marmose-6-phosphate;  MLN, 
mesenteric  lymph node;  PN, peripheral  lymph  node;  pnHR, peripheral 
lymph node homing receptor;  PP, Peyer's patches. 
tially defined in the mouse by the mAb MEL-14 (Gallatin et 
al.,  1983). This antibody selectively  recognizes a cell sur- 
face protein of ~90 kD (gp90MEL), blocks lymphocyte at- 
tachment to PN HEV in the Stamper-Woodruff in vitro ad- 
herence  assay  and  prevents  in  vivo migration  to  lymph 
nodes.  A  homing  function  for  gp90  MEL  was  definitively 
shown  by  the  finding  that  the  receptor,  as  a  detergent- 
solubilized  molecule or as a soluble recombinant protein, 
can selectively block adhesive  sites for lymphocytes on PN 
HEV but not those on PP HEV (Geoffroy and Rosen, 1989; 
Watson et al.,  1990). 
A lectin activity for gp90  MEL and its homologs in other 
species  was  initially  inferred  based  upon  the  ability  of 
specific phosphorylated monosaccharides, such as mannose- 
6-phosphate (M6P), and specific polysaccharides to prevent 
lymphocyte  attachment  to  HEV  (Stoolman  and  Rosen, 
1983; Stoolman et al.,  1984; Yednock et al.,  1987a; Stool- 
man  et al.,  1987; Stoolman  and  Ebling,  1989).  Notable 
among the active  polysaccharides are PPME (a M6P-rich 
mannan  core) and  fucoidin (a  sulfated,  fucose-rich poly- 
mer). Subsequently,  it was shown that gp90  MEL either on the 
lymphocyte surface (Yednock et al., 1987a, b), as a purified 
molecule (Imai et al.,  1990), or as a recombinant molecule 
(Watson et al.,  1990)  can directly bind to PPME. In all 
cases, MEL-14 completely inhibits  the interaction.  Impor- 
tantly,  this  carbohydrate-binding  activity depends on  the 
presence of calcium, thus mimicking  the calcium require- 
ment for the attachment of lymphocytes to HEV. The lectin 
nature  of gp90  ~EL was confirmed by molecular cloning  of 
the receptor (Lasky et al.,  1989;  Siegelman  et al.,  1989) 
which revealed  a  transmembrane  protein with a  calcium- 
type (C-type), lectin-like  domain at its extracellular  amino 
terminus,  homologous  to  domains  found  in  a  series  of 
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lowing the lectin motif are an EGF motif, two complement 
regulatory motifs related to those found in proteins with 
complement-binding activity, a transmembrane domain, and 
a  short  cytosolic  tail.  That  the  PPME  interaction  with 
gp90  MEL is attributable to the lectin domain is confirmed by 
the mapping of the MEL-14 epitope to this domain (Bowen 
et al.,  1990).  The same basic organization of motifs found 
in gp90  MEL has been discerned for two other adhesion mole- 
cules, ELAM-1 and GMP-140/PADGEM (Bevilacqua et al., 
1989; Johnston et al., 1989), as well as the human homolog 
of  gp90  MEL  (Bowen  et  al.,  1989;  Tedder  et  al.,  1989; 
Camerini  et  al.,  1989;  Siegelman and Weissman,  1989; 
Kishimoto et al., 1990). On the basis of sequence homology, 
domain organization, and function, the pnHR,  GMP-140, 
and ELAM-1 constitute a new gene family of cell-cell adhe- 
sion proteins, designated as LEC-CAMs (Stoolman, 1989) 
or selectins (Geng et al.,  1990;  Springer,  1990). 
From the lectin nature of the pnHR, the cognate HEV- 
ligand is presumed to bear a carbohydrate-based recognition 
determinant. Early studies demonstrated that the adhesive 
sites  on  PN  HEV  are  periodate  sensitive  (Rosen  et  al., 
1985),  indicating a  requirement for carbohydrate. Subse- 
quently, it was demonstrated that sialidase treatment of HEV, 
in vitro or in vivo, selectively eliminates lymphocyte  attach- 
ment to PN HEV but has no effect on the binding to PP HEV 
(Rosen et al., 1985, 1989). In addition, exposure of PN tis- 
sue sections to Limax flavus agglutinin, a sialic acid-specific 
lectin, prevents lymphocyte attachment to HEV (True et al., 
1990).  These early observations have recently been con- 
firmed and extended with the use of a recombinant chimeric 
receptor, consisting of the extracellular domains of gp90  M~ 
joined to the Fc region of human IgGt and designated as 
LEC-IgG to indicate the presence of the (L)ectin, (E)GE 
and (C)omplement-regulatory motifs (Watson et al., 1990). 
This reagent, when used as the basis of a histochemical stain, 
reacts selectively with PN HEV. Trea~nent of PN tissue sec- 
tions with either sialidase or Limax agglutinin eliminates 
staining of PN HEV by LEC-IgG (True et al.,  1990). 
While these previous studies provide direct evidence for 
the existence of a specific HEV-ligand for the pnHR and indi- 
cate a functional requirement for sialic acid, the biochemical 
nature of this ligand has heretofore not been defined. Based 
upon adhesion-blocking activity and selective staining of PN 
HEV by MECA-79  mAb, a candidate for the ligand exists 
among the complex of proteins recognized by this antibody 
(Butcher,  1990).  In the present study, we use LEC-IgG to 
identify a ligand for the pnHR as a sulfated, fucosylated and 
sialylated glycoprotein of 50 kD.  A glycoprotein of 90 kD 
with similar characteristics is also identified. 
Materials and Methods 
Reagents 
Fucoidin, keratan sulfate (bovine cornea), chondroitin sulfate A (bovine tra- 
chea), chondroitin sulfate B  (porcine skin), oq-acid glycoprotein (human 
serum),  trypsin  (TPCK-treated),  soybean  trypsin  inhibitor,  PMSE  and 
aprotinin were purchased from Sigma Chemical Co. (St. Louis, MO); Tri- 
ton X-I00, CHAPS,  and pepstatiu were from Boehringer Mannheim Bit- 
chemicals (Indianapolis, IN).  PPME was purified from Hansenula holstii 
core mannan, kindly provided by Dr. M. E. Slodki (Department of Agricul- 
ture, Northern Regional Research Center, Peroria, IL) and mnn 2 mannan 
was a gift from Dr. C. E. Ballou (Department of Biochemistry, University 
of California, Berkeley, CA).  MEL-14 mAb (rat IgCr2,) was purified on a 
column of recombinant Protein G-Sepharose 4B (Zymed Laboratories Inc., 
South San Francisco, CA) and purified anti-CD45 mAb (M1/9.3.4. HL. 2, 
rat Igl3~a) was a gift of Dr. J. Curtis ('VA Medical Center, San Francisco, 
CA). MECA-79 mAb (rat IgM),  OZ-42 mAb (rat IgM),  and anti-rat Ig- 
agarose were gifts of Drs. E. Berg and E. Butcher (Department of Pathol- 
ogy, Stanford University, Stanford, CA). The mouse peripheral lymph node 
homing receptor-human IgGl chimera (LEL-IgG) and CD4-human IgGt 
chimera (CD4-IgG) were prepared as previously described (Watson et al., 
1990; Capon et al.,  1989). 
Metabolic Labeling of Organs with ~S-sulfate 
or 3H-sugars 
Mesenteric or peripheral (cervical, brachial, and axillary) lymph nodes 
were collected from 8-16-wk-old female ICR mice. The LN were cut into 
I-ram-thick slices with a razor blade and the slices (typically 0.2 g of wet 
weight) were suspended in 1 ml of RPMI-1640 containing 25 mM Hepes, 
100 U/nd Penicillin G,  100 #g/ml streptomycin, and 200/xCi carrier-free 
[3~S] sodium sulfate (ICN  Radiochemicals,  Irvine, CA) according to the 
procedure of Ager (1987). For metabolic labeling with sugars, mesenteric 
and peripheral LN slices (0.07 g  of wet weight) were labeled in 1 ml of 
medium  containing  100  /zCi  of  either  [5,6-3H]-L-fucose,[2-3H]-D-man  - 
nose, or [6-3Hl-glucosamine hydrochloride (New England Nuclear,  Bos- 
ton,  MA).  The above medium  was  also  used  for  fucose  labeling.  For 
glucosamine and manaose labeling, glucose-free RPMI-1640 with 1 mM 
sodium pyruvate was used. After incubation at 37°C for 4 h, the slices were 
washed extensively in Dulbecco's PBS, and then homogenized in 1 ml of 
lysis buffer (2% Triton X-100 in PBS containing 1 mM PMSF, 1% [vol/vol] 
aprotinin,  10  /~g/mt  pepstatin,  0.02%  NAN3)  with  a  Potter-Elvehjem 
homogenizer on ice.  The other tissues (Peyer's patches, spleen, thymus, 
liver, kidney, and brain) were labeled and homogenized by the same proce- 
dure with the volumes of labeling medium and lysis buffer based on the wet 
weight of the tissue. Lysis was continued for 1 h on a rocker at 4°C.  The 
lysate was centrifuged at 10,000 g for 1 h at 4°C. EDTA was added to the 
supernatant at a  final concentration of 2  mM  and the supernatant was 
precleared by rocking with Afli-Gel Protein A (250 td of packed beads, Bit- 
Rod Laboratories,  Richmond, CA) overnight at 4°C. 
Identification of the Components Adsorbed 
to LEC-IgG Beads 
Afti-Gel Protein A (10/~1 packed beads) was incubated with 30 ~g of either 
LEC-IgG,  CD4-IgG,  or  human  IgG~  (Calbiochem-Behfing Corp.,  San 
Diego, CA) in 1 m/of PBS rocking overnight at 4°C. The beads (referred 
to as LEC-IgG beads, CD4-IgG beads, and hulgG-beads) were washed 3x 
in PBS and once with tysis buffer. The precleared lysate was centrifuged 
at 10,000 g  for 10 s, CaCI2 was added to the supernatant at a final concen- 
tration of 5 raM, and the supernatant was mixed immediately with either 
LEC-IgG  beads,  CIM-IgG beads,  or  httlgG-beads  (typically  200/~1  of 
preeleared lysate per I0 #1 packed beads), and incubated for 4 h at 4*C on 
a rocker. The beads were washed 6× with Iysis buffer, transferred to a new 
tube, and then washed once more with lysis buffer. The materials bound to 
the beads were solubilized by boiling in SDS in the presence of 2-rnercap- 
toethanol, electrophoresed on SDS-polyacrylamide gels (9 or  10%) and 
subjected to fluorography with ENTENSIFY  or EN3HANCE  (New  En- 
gland Nuclear). By fluorography, the 50-kD component tended to be more 
diffuse with ENTENSIFY  than EN3HANCE.  In the repreeipitation ex- 
periment, the SDS-solubilized sample was electrophoresed on a 7.5% SDS- 
gel with prestained standards (BioRad; high range) as markers. The region 
•50  kD on the get was excised by using prestained ovatbumin (49.5 kD) 
as a position marker, and the protein electroeluted (model 422; BioRad) into 
Laemmli running buffer at 60 mA overnight. The eluate was concentrated 
and the buffer was exchanged into 10 mM CHAPS in PBS on a Centricon 
30 unit (Amicon Corp., Danvers, MA), followed by incubation with LEC- 
IgG beads or CD4-IgG heads as descr/bed above. For the analysis of crude 
lysate, 200 ttl of the precleared lysate was precipitated with cold acetone 
(80% voltvol) and then subjected to electrophoresis as above. 
Effects of  MEL-14 mAb and Polysaccharides 
For testing the effect of antibodies, LEC-IgG beads (10/~1 packed beads), 
prepared as described above, were incubated with rat serum (0.5 ml,  1:5 
dilution in PBS) for 40 rain at 4°C. The beads were washed with lysis buffer 
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and resuspended in 0.5 ml of the same buffer. 100 p.g of rat mAb (MEL-14 
mAb or anti-CD45 mAb) was added to the beads and incubated for 30 min 
at 4°C.  The  calcium-restored precleared lysate was  then added  to the 
antibody-treated LEC-IgG beads, and the beads were processed as de- 
scribed above. For testing the effect of polysaccharides,  LEC-IgG beads (10 
/~1 packed) were preincubated with polysaccharides  in lysis buffer for 30 min 
at 4°C before adding the calcium-restored precleared lysate. 
Effect of Sialidase 
Material bound to the LEC-IgG beads (50/~1 packed) was eluted by treat- 
ment with 300/zl of elution buffer (3 mM EDTA, 0.2 % Triton X-100 in PBS 
containing 1 mM PMSF,  1% [vol/vol] aprotinin, 10 #g/ml pepstatin) over- 
night at 40C. The beads were removed by centrifugation and the pH of the 
eluate was adjusted to pH 5 with acetic acid. To 100/~1  aliquots of the eluate, 
0.1 U of Arthrobacter ureafaciens  sialidase (Calbiochem-Behring Corp.) in 
10 t~l of 0.5 M acetate buffer, pH 5.0, or 10 #1 of the acetate buffer alone 
was added.  After incubation for 2 h at 37°C, 45/A aliquots were removed 
for SDS-PAGE analysis.  To the remainder (65 td), CaCI2 was added to a 
final concentration of 6 mM. The calcium-restored eluate was diluted in the 
lysis buffer (1 ml),  incubated with LEC-IgG beads (10 ttl packed), and 
processed as described above. 
Effect of Trypsin 
The eluate from LEC-IgG beads was prepared as above except that protease 
inhibitors were not included in the elution buffer. The pH of the eluate was 
adjusted to pH 8.0 with Tris (Bio-Rad Laboratories, Richmond, CA). The 
eluate was treated with trypsin (100 izg/rnl) in the presence or absence of 
soybean trypsin inhibitor (200 #g/ml) for 4 h at 37°C  and then analyzed 
by SDS-PAGE. 
Immunoprecipitation by MECA-79 Antibody 
Anti-rat Ig-agarose (20/xl packed beads) was armed with either MECA-79 
mAb or class-matched control OZ-42 mAb (13 #g protein) by overnight in- 
cubation at 4°C. The beads were washed three times with PBS and then once 
with 0.2% Triton X-100 in PBS. 60/~1 of the EDTA eluate from LEC-IgG 
beads (containing protease inhibitors), after calcium restoration (5 raM), 
was incubated either with MECA-79 beads or with OZ-42 beads for 2 h at 
4°C. 45 #1 of the supernatant and the material bound to the beads were sub- 
jected to SDS-PAGE analysis. 
N-glycanase Treatment 
The eluate from LEC-IgG beads was prepared as above except that 10 mM 
CHAPS was used in place of Triton X-100, followed by concentration and 
exchange of buffer into 10 mM CHAPS, 0.15 M NaCl (containing 1 mM 
PMSE  1% [vol/vol] aprotinin) on a Centricon 30 unit. For N-glycanase 
treatment, 20 ttl aliquots of the concentrated sample or ~q-acid glycopro- 
tein (24 #g) were boiled for 5 min in 0.5%  SDS with 0.1  M 2-mercap- 
toethanol. The denatured samples were treated with or without 16 Genzyme 
U/ml of recombinant N-glycanase  (Genzyme Corp., Boston, MA) in the 
presence of 0.2 M sodium phosphate, pH 8.4,  10 mM 1,10-phenanthroline 
(Sigma Chemical Co.),  1.25% Triton X-100, 0.17% SDS, 0.03 M 2-mer- 
captoethanol in a volume of 60 #1 for 16 h at 37°C. 
Results 
Mouse PN Homing Receptor-IgG Chimera 
(LEC-IgG) Precipitates a 50-kD Component from 
pJS]Sulfate-labeled Lymph Nodes 
Strong sulfate incorporation into macromolecules is a dis- 
tinctive characteristic of lymph node high endothelial cells 
in situ and in cell culture (Ager, 1987; Andrews et al., 1982; 
Ise et al., 1988).  Furthermore, among the most active sub- 
stances in competing the lectin activity of gp90  MEL or LEC- 
IgG are fucoidin, sea urchin egg jelly fucan, and sulfatide, 
all of which are sulfated macromolecules (Imai et al., 1990; 
Watson et al., 1990).  In light of this information, we exam- 
ined whether LEC-IgG immobilized on beads could bind 
35SO4-1abeled macromolecules  from lymph nodes,  which 
had been metabolically labeled in organ culture in the pres- 
ence of [3sS]sodium  sulfate (Fig.  1).  Fig 2  a  shows that 
LEC-IgG beads  precipitated  a  diffuse 50-kD  component 
(range is 40-58  kD)  from [3~S]sulfate-labeled  mesenteric 
lymph nodes (MLN) or PN.  A band of '~90 kD (83-102 
kD), relatively minor in terms of sulfate incorporation, was 
also observed in most analyses. In control precipitations, hu- 
man IgGrconjugated beads did not recognize the 50-kD 
major component or the 90-kD component in PN or MLN 
lysates. When crude lysates of MLN and PN were directly 
analyzed (Fig. 2 a), the 50-kD component represented the 
major constituent among several other bands. The tissue dis- 
tribution of the 50-kD component was further examined by 
applying the identical protocol for [35S]sulfate labeling and 
precipitation with LEC-IgG to a number of organs. Among 
lymphoid tissues, only PN and MLN showed the 50- and 90- 
kD bands, while PE spleen, and thymus were negative for 
both (Fig. 2 b). Noniymphoid organs such as kidney, liver, 
cerebrum,  and cerebellum were also completely negative 
(Fig. 2, b and c). 
Characteristics of the Interaction between LEC-IgG 
and the 50-kD Component 
The interaction between pnHR and its HEV ligand is calcium 
dependent, since the specific staining of PN HEV by LEC- 
IgG is eliminated by EGTA (Watson et al., 1990). Moreover, 
a calcium requirement has been shown in an ELISA assay 
that measures the interaction between pnHR and PPME, a 
carbohydrate-based ligand analog (Imai et al., 1990).  In ac- 
cordance with these results, LEC-IgG beads precipitated the 
50-kD component when calcium was present, but not in its 
absence (Fig. 3 a). The specificity of the interaction was fur- 
ther  examined with  the  use  of MEL-14  mAb,  which  is 
directed to the lectin domain of pnHR (Bowen et al., 1990). 
As shown in Fig. 3 b, preincubation of LEC-IgG beads with 
this antibody completely blocked the binding of the 50-kD 
band to the beads, whereas a class-matched control antibody 
(anti-CD45)  had no effect.  Previously, the histochemieal 
staining of PN HEV by LEC-IgG was shown to be inhibited 
lanai et ai. A Ligand for a Lymphocyte-homing Receptor  1215 Figure 2.  Tissue distribution  of sulfated components recognized by LEC-IgG. Tissue slices from various organs were incubated with 
laSS]sulfate and detergent lysates were prepared and precleared with Affi-Gel Protein A in the presence of EDTA. After calcium was re- 
stored, the lysates were precipitated with Affi-Gel Protein A coated with human IgGt (IgG), or LEC-IgG. (a) Peripheral lymph nodes 
(PN) and Mesenteric lymph nodes (MLN). The labeling and extraction conditions were as follows: 0.12 g of tissue slices was labeled with 
200 #Ci of laSS]sulfate and extracted with 1 ml lysis buffer; 200/~1 lysate was used for precipitation; for analysis of crude lysates, 200/zl 
of each lysate was precipitated with 80% cold acetone before electrophoresis. (b) MLN, cerebellum, thymus, spleen, PP. 0.2 g of tissue 
slices was labeled with 200 t~Ci of [aSS]sulfate, extracted with 1 ml lysis buffer and processed as above except 400 #1 was used for precipi- 
tation. (c) MLN, cerebrum, kidney,  and liver.  0.15 g of tissue was labeled and extracted as above with 450 #1 used for precipitation. The 
precipitates were solubilized with SDS under reducing conditions and analyzed by SDS-PAGE on a  10% gel (a) or on 9% gels (b and 
c) and subjected to fluorography using ENaHANCE (a and c) or ENTENSIFY (b). The molecular weight markers (Bio-Rad Laborato- 
ries) are shown on the right: phosphorylase B (92.5 kD), BSA (66.2 kD), ovalbumin (45 kD), carbonic anhydrase (31 kD), soybean trypsin 
inhibitor (21.5  kD), Iysozyme (14.4 kD). (df) The position of the dye front. In a  the higher intensity of the 50-kD component in PN as 
compared to that in MLN may reflect the greater abundance of the molecule in PN. This result would be predicted for the biological ligand 
for the pnHR, since PN HEV exhibits a single-adhesive specificity,  whereas MLN HEV appear to represent a hybrid specificity of both 
PN and PP (Butcher et al.,  1980;  Rosen et al.,  1985;  Streeter et al.,  1988a). 
by fucoidin (Watson et al.,  1990), consistent with the ability 
of this polysaccharide to block lymphocyte attachment to PN 
HEV (Stoolman and Rosen,  1983; Yednock et al.,  1987a) as 
well as to compete for PPME  binding  to the pnHR in the 
ELISA  assay.  As  shown  in  Fig.  4,  fucoidin  completely 
blocked the precipitation of the 50-kD component by LEC- 
IgG beads,  while control polysaccharides  (chondroitin  sul- 
fate B, chondroitin sulfate A, keratan sulfate) were completely 
inactive.  Furthermore,  the presence of PPME  significantly 
reduced  the intensity of the 50-kD band (Fig.  4),  although 
a relatively high concentration was required.  A control yeast 
mannan (mnn 2) had no effect at the same concentration.  The 
precipitation  of the minor 90-kD  band by LEC-IgG beads 
was also calcium dependent (Fig. 3 a), inhibitable by MEL-14 
mAb (Fig. 3 b), and blocked by fucoidin and PPME (Fig. 4). 
Effect of Sialidase Treatment 
Our previous experiments have shown that sialic acid on the 
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interaction  between  LEC-IgG and  the  50-kD  component.  (a) 
[35S]sulfate-labeled  lysate  from MLN  was  precleared  and  then 
precipitated  with  LEC-IgG in the  presence  (+ Ca)  or  absence 
(-Ca) of  calcium. (b) Precleared lysate was precipitated with LEC- 
IgG that had been treated with rat serum alone (rat serum), rat se- 
rum and MEL-14 mAb (MEL-14), or rat serum and anti-CD 45 
mAb (anti-CD45). The precipitates  were analyzed by SDS-PAGE 
(10% gel) and fluorography.  The 50-kD band in b is compacted as 
a result of unlabeled immunoglobnlin heavy chain, released  from 
the beads,  which migrates just above the sulfate-labeled  compo- 
nent.  In a  (+ Ca), the faint  90-kD band  is  indicated  by an ar- 
rowhead. 
HEV-ligand itself or on closely associated molecules is criti- 
cal for recognition by the pnHR. We, therefore, sought to de- 
termine  if the 50-kD component was  sialylated  and if so, 
whether  sialic  acid was necessary for its binding to LEC- 
Figure 4.  Effect  of polysaccharides on the  interaction  between 
LEC-IgG chimera and  the 50-kD component.  Precleared lysate 
prepared from a mixture of [35S]sulfate-labeled MLN and PN was 
precipitated with LEC-IgG in the presence of  polysaccharides.  The 
LEC-IgG beads were preincubated with mrm2 mannan (510 #g), 
PPME (510 #g), chondroitin sulfate B (CS-B; 51 #g), chondroitin 
sulfate A (CS-A; 51 #g), keratan sulfate  (KerS; 51 #g), fucoidin 
(Fuc; 51 #g), or without polysaccharides (None) in 670 #1 of the 
lysis buffer. After 30 min at 4°C,  170/zl of the precleared lysate 
was added to each of the bead mixtures and allowed to react for 4 
h. The bound material  was analyzed by SDS-PAGE (10% gel) and 
fluorography.  In this experiment,  several distinct bands are evident 
within the 50-kD region of  the gel. This banding pattern may reflect 
heterogeneity in glycosylation of the molecule. 
Figure 5.  Effect  of sialidase  on the 50-kD component.  [35S]sul- 
fate-labeled lysate was prepared from MLN and was adsorbed to 
LEC-IgG beads.  Bound material was eluted with EDTA.  Eluted 
material (EDTA eluate) was analyzed by SDS-PAGE (10% gel) and 
fluorography after treatment with Arthrobacter ureafaciens  siali- 
dase (Sialidase),  treatment with buffer alone (pH  5), or without any 
treatment (None). Separate aliquots of buffer- and sialidase-treated 
eluate were reexposed  to fresh LEC-IgG (Reprecipitated) and the 
bound  material  was  subjected  to  analysis  by  SDS-PAGE  and 
fluorography.  The 90-kD band is diffuse in EDTA eluates because 
there is no compaction in the gel by the LEC-IgG  component which 
runs at a similar position. The diffuse band for the control material 
(None) is indicated  by an arrowhead.  Sialidase  treatment changed 
the mobility of the 90-kD band and inhibited  its reprecipitation  by 
LEC-IgG. 
IgG. After EDTA elution of the 50-kD band from LEC-IgG, 
it was treated with Arthrobacter ureafaciens sialidase or con- 
trol buffer. Sialidase treatment caused a marked increase in 
electrophoretic  mobility,  while  the  buffer-treated  material 
was  unaffected  (Fig.  5).  Upon  reprecipitation  with  fresh 
LEC-IgG beads, the control-treated material was adsorbed, 
whereas the sialidase-treated material was no longer recog- 
nized by LEC-IgG (Fig. 5).  A  similar dependence on sialic 
acid was observed for the 90-kD component (Fig.  5). 
The Protein Nature of the 50-kD Component 
To determine whether the 50-kD component was a protein, 
its sensitivity to trypsin was examined.  The component was 
released from LEC-IgG beads with EDTA and treated with 
trypsin in the absence or presence of soybean trypsin inhibi- 
tor. The molecular weight of  the sulfate-labeled band was re- 
duced to ,024 kD after trypsin treatment (Fig. 6). The inclu- 
sion of trypsin inhibitor completely blocked this degradation. 
The 90-kD band was also substantially degraded by the tryp- 
sin treatment  (Fig.  6). 
Precipitation by MECA-79 
The MECA-79 mAb recognizes a complex of heterogeneous 
glycoproteins, for which only a preliminary characterization 
has been published to date (Butcher,  1990). To determine if 
the 50-kD component could be precipitated by MECA-79, an 
EDTA eluate from LEC-IgG, obtained as described above, 
was exposed to MECA-79-conjugated beads.  As shown in 
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the 50-kD component. Lysate 
was prepared  from a mixture 
of  [35Slsulfate-labeled MLN 
and PN and was adsorbed to 
LEC-IgG  beads. Bound mate- 
rial was eluted with EDTA in 
the absence of  protease inhibi- 
tors. The eluate was analyzed 
by SDS-PAGE (10% gel) and 
fluorography  after  treatment 
with  trypsin  (Try), treatment 
with trypsin plus soybean tryp- 
sin inhibitor (Try +  I), expo- 
sure to buffer at 37°C (37~C), or incubation with buffer on ice 
(O°C). The diffuse 90-kD band is indicated by an arrowhead in the 
control condition (37°C). Trypsin substantially reduced the inten- 
sity of the 90-kD component. 
Figure 8.  Effects of N-glyca- 
nase  treatment  on  the  50- 
kD  component.  [35S]sulfate- 
labeled lysate from a mixture 
of  MLN and PN was adsorbed 
to LEC-IgG  beads with elution 
of bound material  by EDTA. 
The  EDTA eluate  was  ana- 
lyzed by SDS-PAGE  (10% gel) 
and  fiuorography  after treat- 
ment  with  N-glycanase  (N- 
gly), or exposure to the appro- 
priate  control  buffer (37°C). 
As a control, cq-acid glycoprotein (co-GP) was analyzed after the 
treatment,  and protein  was detected by Coomassie brilliant  blue 
G (Sigma Chemical Co.). The faint 90-kD band is indicated by an 
arrowhead in the control condition (37°C). 
Fig. 7, the band was adsorbed to the beads and was quantita- 
tively depleted from the supernatant  fraction.  In contrast, 
when beads conjugated to a  class-matched antibody (mAb 
OZ-42) were used, the component remained in the superna- 
tam. The 90-kD band was also specifically precipitated by 
MECA-79 mAb (data not shown). 
Nature of  Sugar Chains on the 50-kD Component 
To characterize further the glycoprotein nature of the 50-kD 
component, we tested the sensitivity of an EDTA eluate from 
LEC-IgG beads to N-glycanase treatment.  N-linked sugar 
chains are known to be cleaved by the treatment. As shown 
Figure Z  Precipitation  of the 50-kD  component  with MECA-79 
mAb.  Lysate  prepared  from  a  mixture  of  [35S]sulfate-labeled 
MLN and PN was adsorbed to LEC-IgG beads with elution of the 
bound material by EDTA. The eluate was incubated with immobi- 
lized MECA-79 mAb (MECA-79) or control class-matched mAb 
(0Z-42). The material remaining in the supernatant (supernatant) 
and that bound to the immobilized mAbs (precipitate) were ana- 
lyzed by SDS-PAGE (10% gel) and fluorography. Untreated eluate 
was also analyzed  in parallel  (control). The band shown in the 
MECA-79"precipitate" is compacted as a result of  unlabeled immu- 
noglobulin  heavy chain,  which  migrates just about  the  sulfate- 
labeled component. MECA-79 mAb also precipitated the minor 90- 
kD band, which was visible with longer exposure (data not shown). 
in Fig. 8, N-glycanase treatment did not affect either the in- 
tensity of the 50-kD band or its electrophoretic mobility, in- 
dicating  that  N-linked  sugar chains  were not a  significant 
carbohydrate constituent.  The minor 90-kD band was also 
unaffected by the N-glycanase treatment (Fig. 8). In contrast, 
a  control glycoprotein (at-acid glycoprotein) yielded a  se- 
ries of deglycosylated products upon N-glycanase treatment 
performed under the same conditions (Fig.  8). 
Metabolic Labeling of  Lymph Nodes with Sugars 
To  characterize  its  sugar  chains  further,  we  determined 
whether [3H]precursor monosaccharides could be metabol- 
ically incorporated into the 50-kD component. Lymph nodes 
were labeled with  [3H]fucose,  [3H]glucosamine,  [3H]man- 
nose, or [35S]sulfate. The extracts were subjected to two cy- 
cles  of adsorption  to  either  LEC-IgG beads  or  CD4-IgG 
beads with elution by EDTA. As shown in Fig. 9 a, LEC-IgG 
beads bound the 50-kD component from both the  fucose- 
and  sulfate-labeled lysates but no bands were precipitated 
from the glucosamine-labeled or mannose-labeled lysates. 
CD4-IgG beads failed to react with components in any of the 
lysates. In another experiment, in which one cycle of adsorp- 
tion to LEC-IgG beads was used,  a  fucose-labeled 90-kD 
component was observed in addition to the 50-kD compo- 
nent (data not shown). As expected, numerous glycoproteins 
of various molecular weights incorporated fucose and glucos- 
amine when crude lysates (in amounts comparable to those 
used  for precipitation)  were directly  analyzed (Fig.  9  b). 
Thus, the 50-kD fucose-labeled component that was precipi- 
tated by LEC-IgG represented a  minor component among 
many fucosylated glycoproteins. 
Reprecipitation of the 50-kD Component 
after Electroelution from SDS-gel 
To establish if the 50-kD band could be recognized directly 
by LEC-IgG, we carried out the following reprecipitation ex- 
periment.  LEC-IgG beads  that  had  been  incubated  with 
[3~S]sulfate-labeled  lymph  node  lysate  were  boiled  with 
SDS in the presence of 2-mercaptoethanol at 100°C to elute 
the bound material. The eluted materials were electropho- 
resed on an SDS-gel, and the region corresponding to 50 kD 
was excised. The materials were electroeluted from the gel 
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ration into the 50-kD component. 
MLN and PN were labeled in or- 
gan culture with [3H]fucose  (Fuc), 
[3H]glucosamine  hydrochloride 
( GlcNH2 ) , [3H]mannose  (Man), or 
[35S]sulfate  (SO,O. (a) Precipitation 
of labeled lysates with LEC-IgG or 
CD4-IgG. The labeled lysates were 
adsorbed to either LEC-IgG beads 
or CD4-IgG beads (an amount of 
lysate corresponding to 0.035-g wet 
tissue weight  was used for  each lane), 
and the bound material was eluted 
with EDTA, followed by reprecipi- 
tation with either LEC-IgG beads 
or CD4-IgG  beads  after calcium 
restoration.  The  bound  material 
was again eluted with  EDTA and 
then analyzed by SDS-PAGE  (10% gel) and fluorography. (b) Analysis of crude lysates. An amount of each lysate, equivalent to that used 
in a, was precipitated with cold acetone and analyzed by SDS-PAGE and fluorography. 
slice and subjected to reprecipitation by LEC-IgG beads or 
by CD4-IgG beads as a control. As shown in Fig. 10, the 50- 
kD  band  was  reprecipitated by LEC-IgG beads,  whereas 
CD4-IgG beads showed no reaction. 
Discussion 
The  LEC-IgG  chimeric  receptor  represents  a  seemingly 
ideal reagent for the identification of the pnHR HEV-ligand, 
since it was engineered to contain all of the extracellular do- 
mains of gp90  MEL, the bonafide pnHR in mouse. Extensive 
characterization has established that the recombinant mole- 
cule does, indeed, reflect all of the known recognition prop- 
erties of the native receptor: (a) it binds to PN HEV in an 
organ-specific  manner;  (b)  its  interaction  with  HEV  is 
blocked by the same carbohydrates that inhibit lymphocyte 
attachment to PN HEV; (c) its binding to HEV is both cal- 
cium dependent and MEL-14 mAb inhibitable as observed 
for the binding of lymphocytes to HEV; and (d) it retains the 
calcium-dependent, carbohydrate-b'mding  activity of gp90  ~mL, 
as measured in a quantitative ELISA assay. Using this highly 
validated reagent as the basis of an affinity matrix, we have 
precipitated a  50-kD component from [35S]sulfate-labeled 
lymph nodes.  We designate the component as  Sgl  ~° (sul- 
fated glycoprotein of 50 kD). The precipitation of SgtP  ° de- 
Figure 10. Repreeipitation  of  the 50-kD 
component after its electroelution from 
an SDS gel. [35S]sulfate-labeled  lysate 
from a mixture of MLN and PN was ad- 
sorbed to LEC-IgG beads. Bound ma- 
terial was boiled in Laemmli sample 
buffer (containing 2% SDS and 0.7 M 
2-mercaptoethanol)  and  electropho- 
resed on a 7.5% SDS-gel. The 50-kD 
region was excised and electroelnted 
material was reexposed to fresh LEC- 
IgG (LEC) or CD4-IgG (CD4).  The 
bound material was boiled in Laemmli 
sample buffer and analyzed by SDS- 
PAGE (10% gel) and fluorography. 
pends on an interaction with the C-type lectin domain of 
LEC-IgG as deduced from MEL-14 inhibition, the require- 
ment for calcium, and competfive inhibition by the specific 
polysaccharides  fucoidin  and  PPME.  It  is  inferred  that 
Sgp  5° is associated with HEV based on the known propen- 
sity of SO4 to incorporate into HEV-associated macromole- 
cules (Andrews et al.,  1982) and the selective staining of 
HEV by LEC-IgG (Watson et al.,  1990). Furthermore, as 
predicted for an organ-specifc HEV ligand, the component 
was not detected in other organs, including several lymphoid 
organs. In further support of its ligand function, the binding 
of Sgl  ~° to LEC-IgG was critically dependent upon its sial- 
ylation.  Thus,  the  functional requirement for sialic  acid, 
originally deduced from cell-binding assays (Rosen et al., 
1985) and supported by histochemical staining experiments 
with LEC-IgG (True et al.,  1990) is now confirmed at the 
level  of an  identified  HEV-associated  molecule.  Finally, 
Sgl  9° draws important support as an adhesive ligand by vir- 
tue of its precipitation with MECA-79, an adhesion-blocking 
mAb reactive with PN HEV (Streeter et al., 1988b). Hereto- 
fore, the functional target of  this antibody has not been clear, 
since it precipitates a heterologous set of proteins (Butcher, 
1990). 
That the  precipitation of Sgp  5° with  LEC-IgG was  be- 
cause of the contribution of LEC to the chimera is clearly 
indicated by the inhibition results obtained with MEL-14, 
specific carbohydrates,  and  calcium depletion.  As  further 
evidence for the specificity of this interaction, we showed 
that Sgp  5° was not precipitated by either human IgG or the 
CD4-IgG  chimera.  The latter control established directly 
that the precipitation of Sgp  5° was not attributable to an un- 
usual characteristic intrinsic to cell-adhesion molecule-im- 
munoglobulin chimeras (Capon et al.,  1989). With respect 
to the selectivity of the interaction between LEC-IgG and 
Sgp  5°,  we  found  that  the  chimera  precipitated  SgI~  not 
only from [35S]sulfate-labeled lymph node lysates but also 
from a  [3H]fucose-labeled lysate,  but  did  not precipitate 
any detectable bands from either pH]glucosamine- or [3H]- 
mannose-labeled lysates. In the case of sulfate labeling, the 
50-kD band was a major component among a limited num- 
ber of bands, and thus one might argue that precipitation of 
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ponent in the  lysate.  However,  as  shown for fucose and 
glucosamine and as presumed for mannose, there are numer- 
ous labeled components. Yet, only the 50- and 90-kD bands, 
which represented minor components of the [3H]fucose-la- 
beled lysate were precipitated, while there were no detectable 
bands  precipitated  from  either  the  [3H]glucosamine-  or 
[3H]mannose-labeled lysate.  Despite the fact that glucos- 
amine is a precursor of sialic acid, the 50-kD band was not 
significantly labeled with glucosamine. This result may be 
explained by a dilution effect, since glucosamine is incorpo- 
rated into several monosaccharides (Cummings et al., 1989). 
It might be argued that proteins that are not sulfated or 
fucosylated could tightly associate with Sgp  5°, and its pre- 
cipitation could result from an interaction between LEC-IgG 
and one of these associated proteins.  However,  when the 
denatured Sgl  :° was electroeluted from an SDS-gel and the 
eluted material reexposed to LEC-IgG, the reprecipitated 
material again showed the 50-kD band by SDS-PAGE analy- 
sis. The fact that CD4-IgG did not reprecipitate the 50-kD 
band after electroelution again assured the specificity of in- 
teraction. Thus, the possibility of co-precipitation of Sgp  5° 
is essentially ruled out.  This result also shows that Sgp  5° 
precipitates independently of the 90-kD component. A di- 
rect interaction between LEC-IgG and Sgp 5° is clearly indi- 
cated. 
Taken together, the evidence argues strongly that Sgp  5° is 
an HEV ligand for the pnHR. At this point, although limited 
information is available about its structure, we can conclude 
that the ligand is a sulfated, fucosylated, and sialylated gly- 
coprotein with trypsin-sensitive core protein. The nature of 
sugar chains of Sgp  5° requires  further study.  The present 
study suggests that N-linked sugar chains are not a major 
constituent, since N-glycanase treatment did not affect either 
the  mobility  or  the  intensity  of the  [35S]sulfate-labeled 
Sgp  5°.  It remains a possibility that the presence of sulfate 
on an N-linked sugar chain could potentially interfere with 
the action of N-glycanase. However, examples are known of 
sulfated N-linked sugar chains that are susceptible to N-gly- 
canase  (Roux et al.,  1988;  Green and Baenziger,  1988). 
When the sulfate- or fucose-labeled Sgl  9° was subjected to 
alkaline  borohydride, a treatment  designed  to release O-linked 
chains, labeled oligosaccharide chains were detected by gel 
filtration analysis (unpublished observations). These results 
suggest the presence of sulfated, fucosylated, O-linked sugar 
chains on Sgp 5°. 
The LEC-IgG chimera also precipitated a 90-kD sulfated, 
fucosylated glycoprotein from MLN and PN  lysates.  We 
designate this molecule as Sgp  9°. As is the case for the in- 
teraction with Sgp  5°, the precipitation of Sgp  9° was calcium 
dependent,  inhibitable  by  MEL-14  mAb,  inhibitable  by 
specific polysaccharides, and dependent on the presence of 
sialic  acid.  In  addition,  Sgp  9°  was  also  precipitated  by 
MECA-79.  This component may be identical to the promi- 
nent 90-kD component recognized by MECA-79 among sev- 
eral other proteins in a Western blot analysis of lymph node 
(Butcher,  1990).  To understand the  relationship between 
Sgp  9° and Sgp  5°, it will be necessary to compare their pro- 
tein and carbohydrate structures, kinetics of synthesis, steady 
state concentrations, and subceUular localizations. 
The exact role of sialic acid in the adhesive function of 
Sgp  5° (and Sgp  9°) is open to speculation. It is likely that a 
sialyloligosaccharide of Sgp  ~° comprises a  recognition de- 
terminant for the lectin domain of the pnHR.  Specificity 
could derive from the uniqueness of the sialyloligosaccha- 
ride, which is plausible in view of the enormous potential for 
diversity  in  sialylated  structures  (Schauer,  1985).  One 
speculation, for example, is that the novel structure is a here- 
tofore undescribed sulfated and fucosylated sialyloligosac- 
charide, for which M6P and fucoidin (a sulfated, fucose-rich 
polysaccharide) are structural mimics. A second contribution 
to specificity might be based on a valency effect in which a 
sialyloligosaccharide ligand is repeated several times with 
precise spacing on a polypeptide backbone, thus allowing for 
multipoint attachment between pnHR molecules and each 
Sgp  5° molecule. The exact role of sialic acid in the function 
of Sgp  5° awaits a detailed analysis of its carbohydrate chains 
and a definition of the minimal oligosaccharide unit for bind- 
ing to the pnHR. Interestingly, all of  the LEC-CAMs (pnHR, 
ELAM-1, and GMP-140)  exhibit an unusually high concen- 
tration of lysine residues within their lectin domains (Bevi- 
lacqua et al.,  1989;  Bowen et al.,  1989;  Johnston et al., 
1989;  Lasky et  al.,  1989)  which had  suggested (Rosen, 
1989) a common theme of anionic sugar (e.g., sialic acid) 
recognition for this family. In fact, it is now known that the 
ligands  for GMP-140  (Corral  et al.,  1990)  and ELAM-1 
(Phillips et al.,  1990;  Tiemeyer et al.,  1990),  also require 
sialic acid. Detailed structures have even been proposed for 
the ELAM-1  ligand (Lowe et al.,  1990;  Tiemeyer et al., 
1990;  Phillips et al.,  1990;  Walz et al.,  1990). 
Considerable attention will also be directed at the protein 
component of Sgp  ~°.  One possibility is that it serves as a 
backbone or scaffolding for the presentation of carbohydrate 
recognition units. As mentioned above, such a function need 
not be trivial, as the spacing and number of carbohydrate 
units could be critical for optimal multivalent presentation. 
Another possibility is that the protein component of Sgp  5° 
participates directly in recognition by the pnHR. The ability 
of Sgp  ~° to be recognized by LEC-IgG after extensive dena- 
turation (boiling and reduction in SDS) supports the notion 
that carbohydrate binding is sufficient for a productive inter- 
action, which also seems to be the case for ELAM-1 (Lowe 
et al.,  1990;  Tiemeyer et al.,  1990).  A direct recognition 
role  for the protein  component of Sgp  5° is,  however,  not 
ruled out. In fact, recent evidence suggests that the EGF mo- 
tif  of the pnHR may have a direct role in HEV binding, inde- 
pendent of the lectin activity (Siegelman et al.,  1990).  An 
appropriate analogy for the LEC-CAMs may be the pituitary 
N-acetylgalactosamine transferase, which appears  to have 
one binding site for an oligosaccharide chain and a separate 
site for a peptide determinant (Smith and Baenziger, 1988). 
It will be of great interest to determine whether the primary 
structure of the Sgl  y'° protein reveals a potential recognition 
domain for EGF, such as an EGF-receptor motif or another 
EGF motif. Also of interest will be the structural compari- 
son of Sgp  5° with the other LEC-CAM ligands. The intrigu- 
ing possibility is that these ligands, like their cognate recep- 
tors, may also comprise a new gene family. 
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